Fifa appears to have ruled out moving Iran’s matches at this summer’s World Cup to Mexico from the United States.

The president of Iran’s football federation had said negotiations were under way to move fixtures in order to ensure their players’ safety.

It comes amid US and Israeli strikes on Iran, which has responded with attacks on Israel and US-allied states in the Gulf.

However, on Tuesday Fifa said in a statement it was looking forward to nations “competing as per the match schedule”.

The US is co-hosting the World Cup, which takes place between 11 June and 19 July, with Canada and Mexico.

Iran are scheduled to face New Zealand on 16 June and Belgium on 21 June, both in Los Angeles, and Egypt in Seattle on 27 June.

Last week US President Donald Trump said that while Iran are “welcome to the World Cup”, he does not think “it is appropriate” they attend “for their own life and safety”.

“When Trump has explicitly stated that he cannot ensure the security of the Iranian national team, we will certainly not travel to America,” said Iranian football federation president Mehdi Taj in a post, external on a social media account belonging to the Iranian embassy in Mexico.

“We are negotiating with Fifa to hold Iran’s World Cup matches in Mexico.”

A Fifa spokesperson said: “Fifa is in regular contact with all participating member associations, including Iran, to discuss planning for the World Cup.

“Fifa is looking forward to all participating teams competing as per the match schedule announced on 6 December 2025.”

Whether you’re a seasoned hiker, daily commuter, or just someone who loathes lukewarm coffee, a reliable thermos makes all the difference. The best thermal flasks combine vacuum insulation with leak-proof lids, durable exteriors and smart features such as one-handed push buttons or built-in cups.

Testing uncovered a large variation in heat retention, build quality and usability. Some high-performing models kept drinks hot for over 12 hours in wet and windy conditions, while others barely saw us through back-to-back Zooms while working from home.

We tested a wide range, from slim urban styles to rugged designs built for adventure, and assessed each one for thermal performance, ease of use, leak resistance and durability through a series of drop tests, temperature checks and backpack trials. You can read my full reviews below, followed by the answers to some frequently asked questions.

The best flasks: At a glance

How to choose the best flask

Leak-proofing is essential. Look for flasks marketed as fully leakproof, not just spill-resistant, with a secure screw lid and silicone gasket. Ease of cleaning is another deal-breaker. Wide-neck flasks are far easier to rinse, dry and keep hygienic, especially for those who fill their flask with soup, smoothies or milkier brews. An easily hand-washed or dishwasher-safe model is best for daily use.

Weight and grip are important considerations, too. Lightweight flasks are ideal for commutes or day bags, but they mustn’t feel flimsy. Look for powder-coated finishes or textured sleeves for added grip, especially in cold or wet conditions. Finally, it’s worth checking out the brand’s sustainability credentials. Will they offer replacement lids or, better yet, a lifetime guarantee? These are indicators of quality, longevity and less waste in the long run.

How I test flasks

To bring you the best thermos flasks of 2026, I rigorously tested models from best-selling brands like Stanley, Thermos and Hydro. Only the very best made this guide. Each flask was put through a week-long trial in real-life conditions, from cross-country train journeys to all-day hikes in the Lake District, where they were stuffed in rucksacks, left in hot cars and dropped (intentionally) on kitchen floors.

• Insulation performance: I filled each flask with boiling water, recorded the starting temperature and then measured again six hours later. I compared my results with the manufacturers’ claims.
• Capacity: I measured how much liquid each flask actually held. Some couldn’t be filled to the brim due to the lid design or risk of spillage.
• Material and durability: I assessed the flasks’ toughness by performing a one-metre drop test onto hard wooden flooring.
• Lid design and leak-proofing: I examined how easy each lid was to open, drink from and safely reseal. I then shook and inverted full flasks to check for leaks and spills.
• Portability: Weight (both full and empty), grip comfort, handle design and fit in cup holders or backpacks were all considered.

All top-scoring flasks are stored for longer-term testing and comparison. This guide is regularly updated, with new flasks tested upon release. Visit our Who We Are page to learn more about the testing process.

A woman scrambles down the steep embankment cradling a baby in her arms.

A man extends a hand to someone else whose step quickens. The sirens start blaring, a warning that incoming missiles are just minutes away.

We’ve all just pulled over at the side of a busy motorway on the outskirts of Tel Aviv.

The usual rules to head down to a bunker are out of the window – all we can do is find a ditch.

That’s the pattern of life in Israel right now, with alerts still ringing out through the day and night, right across the country.

After the all-clear, we realise missiles have hit neighbourhoods a couple of kilometres away from us.

We head to a built-up area where firefighters are dousing down the flames of cars that have caught fire. The local population has escaped injury.

It’s quite a chaotic scene when we arrive as soldiers seal off the area, warning people to get back.

A 21-year-old woman called Keshet tells us part of an Iranian cluster bomb landed right by her home.

“There was a boom,” she says. “We ran outside and saw the fire. It was like an earthquake – it was very frightening.”

There’s not much complacency. The war is into its third week and people have confidence in Israel’s defence systems to intercept missiles.

Some are getting through and there’s the other very real danger of falling debris from the skies after an interception.

Israel’s defence missiles collide with the incoming missiles from Iran or Hezbollah – and the debris can land absolutely anywhere.

Read more:
Mourners in Lebanon defy Israel’s evacuation orders
How UK might try to keep the Strait of Hormuz open

Kobi Hassonah is angry. He lives next door to a storage container which was destroyed in a blaze when debris fell from an intercepted missile.

When we speak to him, the acrid smell of smoke is still in the air.

“Do they [the Iranians] even know what they’re aiming at?” he says. “They just fire. It landed right next to my house. Of all the places.”

But that notion – that nobody wants to be the unlucky one – is largely still driving people to shelters. Safe spaces underneath their homes or beneath the ground. Not everyone has a safe room in their home.

In an underground car park, we meet 46-year-old Alex Proskurov from the city of Rishon LeZion, just south of Tel Aviv.

“We don’t really care about sitting in a bomb shelter for months,” he says defiantly. “As long as we finish the job once and for all.”

His advice: “Don’t be a hero and it’s going to be fine.”

Iran isn’t causing large-scale casualties in Israel – unlike Israel’s bombs launched on Iran and Lebanon.

But it is successfully engaging in psychological warfare.

Laurence Kemball-Cook founded Pavegen with a simple but ambitious aim: to create affordable off-grid electricity in cities.

“I was looking at new forms of street lighting powered by solar and wind,” he says. “But in dense urban environments neither of those technologies work well. Wind needs to be in the sea or high up, and solar struggles when you’re surrounded by tall buildings.”

Cities, though, have something else in abundance: moving people. As an industrial designer with a fascination with sustainability, he spent five years building prototypes in his bedroom of a system that would harness the kinetic energy of footfall and turn into power.

As with all good inventors, people told him he was crazy; but his breakthrough moment came when he realised a flywheel technology would work. “One step can spin the flywheel for up to 10 seconds, which is good for batteries because it gives continuous power.”

Multiply that by thousands of footsteps, and the output becomes something significant. After a trial at the London 2012 Olympics, where a temporary walkway was fitted with its tiles to power lighting, Pavegen now has installations in 250 sites in 5 countries.

Read the full article here.

Image: Pavegen

Jamie Laing has joked that his gift to celebrate his wife Sophie Habboo’s first Mother’s Day backfired as he videod her breaking down in tears.

The couple are best known for starring together in E4 reality show Made In Chelsea, and they tied the knot in 2023 in a civil ceremony in London before a larger, more extravagant celebration in Seville, Spain.

It was then in June last year that they announced they were expecting their first child together, and in early in December, the they announced their baby’s arrival, as Jamie showed the first photos of him and Sophie with their newborn son, revealing his unique name. He wrote at the time: “Ziggy, you have our whole heart”.

Jamie and Sophie have since given glimpses into their lives as new parents, while keeping their son out of the spotlight as much as possible. But following Mother’s Day in the UK on Sunday (March 15), podcast host Jamie took to social media with a video of his wife in tears.

In the short clip, Sophie, 31, is seen sobbing as Jamie, 37, asks: “Wait, why are you upset?” As she holds her head in her hands, she emotionally responds: “He’s never going to be that small.”

A message across the video read: “POV: When your Mother’s Day present backfires,” while Jamie also captioned the post: “Reminder… Don’t make your wife a photo album of your newborn baby for Mother’s Day.”

It comes after Sophie marked her first Mother’s Day by posting a snap of herself pushing her pram around London, dressed in a black leather jacket and white trousers. She also gave a glimpse at the two-month-old, posting a photo of his feet as they sat at a restaurant table.

Alongside the post, she penned: “15 weeks of being a mama and wow… what a ride it’s been. I didn’t realise it was possible to feel so many emotions all at once. I totally get now what people mean when they say they wish they could freeze time. One minute I’m dreaming about the day I can sleep through a full night again, and the next I’m tearing up at the thought of you not needing me in the night or falling asleep in my arms anymore.

“The emotional rollercoaster is wild, it has changed me in ways I never expected, and I’m so grateful for that. The hardest, most rewarding and most magical little bundle of joy all in one. Being your mama is, and will always be, my greatest achievement and joy and the thing I am most proud of. You really are the missing piece to my puzzle.”

She added: “To all the mamas who have been by my side through these early weeks, I love you. And to all the mamas around the world, you truly are all heroes.”

A washer-dryer seems the perfect space-saving alternative to buying separate washing machines and tumble dryers, and is usually more affordable. Still, you don’t want to get stuck with a subpar combo, which could run up high electricity costs and leave clothes damp after the drying cycle. If this is the case, you may want to buy a cheap-to-run heated clothes airer.

Washer-dryers can cost anywhere from £350 to more than £2,000 but for most people, you’ll still be making a saving compared to buying separate machines. The two main types of washer-dryers are freestanding and integrated, which are fairly self-explanatory, but you can read more about what to look for in a washer-dryer in the FAQs section below.

Freestanding washer-dryers tend to be more popular, which is why I’ve focused on them for this guide. I’ve also asked experts for advice and their own recommendations of specific washer-dryers.

The best washer-dryers: At a glance

How to choose a washer-dryer

Choosing the best size and capacity for your home are key when buying a washer-dryer. “It’s important to check the dimensions to ensure it will fit in your space,” says Gwil Snook, buyer at AO. “Think about the drum size you’ll need. Washer-dryers with up to 7kg capacity are suitable for six trousers and t-shirts or one single duvet. 8-9kg is ideal for eight trousers and T-shirts or a double duvet and 10-11kg suits 10 trousers and T-shirts or one king-size duvet.”

“Remember that the machine’s drying capacity is often 50-70 per cent of the washing load, so factor this into your decision making,” Carly Pearson, buyer at Argos adds. Secondly, consider energy rating. “More efficient models use less water and electricity, so could save money in the long run,” says Pearson. “Some models also offer eco-friendly wash and dry cycles that further reduce energy and water consumption.”

The final thing to consider, says Pearson, is noise level. “If your washer-dryer will live in a part of your home that can’t be shut away to keep quiet, make sure you go for the quieter option.”

How we chose the best washer-dryers

To help you decide which washer-dryer to purchase, I sought the input of experienced buyers Carly Pearson of Argos and Gwil Snook of AO, asking how they choose the washer-dryers to sell at their retailers. They advised me on the best washer-dryers based on factors like energy efficiency, drum size, washing and drying capacity, ease of the control panel, spin speeds and how well they expel water.

As many of the machines below have been recommended by experts rather than tested by us at home, we haven’t scored them. For those that were tested at home, the testing was done by home and appliance writer Emily Peck, who used each machine on a variety of loads including bedding, towels and sports clothes to see how they fare against each other.

Visit our Who We Are page to learn more about the testing process.

Weight-loss injections that have become famous for helping people shed pounds may also help some patients with advanced cancer live longer when the disease has spread to the brain, according to a new study.

These medicines belong to a group of drugs called GLP-1 receptor agonists, and they include Wegovy and Ozempic. They were first developed to treat type 2 diabetes, but over the past few years they have drawn global attention because many people taking them experience significant weight loss.

The new study does not show that these injections directly treat cancer. Instead, it suggests something more subtle but potentially important: they might help some very ill patients live longer.

The study focuses on brain metastases. This happens when cancer cells travel from somewhere else in the body – such as the lung, breast or skin – to form tumours in the brain. Unfortunately, brain metastases are relatively common and usually indicate that cancer has reached a late and dangerous stage.

Many patients in this situation also have type 2 diabetes. This matters because the condition can make serious illness harder to manage. High blood sugar can cause chronic inflammation, damage blood vessels and weaken the body’s ability to cope.

In my own clinical practice, I often prescribe steroids to help patients with brain metastases manage symptoms such as swelling in the brain. Steroids can be very effective, but they also tend to raise blood sugar levels and can make diabetes harder to control. This has led researchers to ask whether GLP-1 drugs might have additional benefits.

When diabetes drugs meet cancer care

Laboratory studies suggest they may protect brain cells, reduce inflammation and help preserve the brain’s blood supply. Until now, however, there has been very little evidence from everyday clinical practice showing how patients with both diabetes and brain metastases fare when they take these medicines.

The new study, published in Jama Network Open, set out to explore that question. Researchers used a medical database of anonymised health records from 151 hospitals and healthcare systems around the world.

They searched for adults who had three conditions: cancer, type 2 diabetes and brain metastases. The records covered patients seen between 2018 and 2024. The researchers were particularly interested in whether these patients had been prescribed a GLP-1 drug – such as semaglutide, dulaglutide, liraglutide or tirzepatide – around the time their diabetes and brain metastases were first diagnosed.

To make a fair comparison, the team matched people who received one of these injections with similar patients who did not. They took into account factors such as age, sex, type of cancer, other medical conditions and treatments including chemotherapy, radiotherapy and steroid use. Statistical matching cannot eliminate every difference between groups, but it helps reduce the risk that the results simply reflect one group being healthier at the start.

In total, the researchers identified more than 19,000 patients with cancer, brain metastases and type 2 diabetes. Among them, 866 had been treated with a GLP-1 drug, while over 11,000 had not. After careful matching, the analysis compared two balanced groups of 850 patients each who were similar in terms of their cancers, body mass index, diabetes control and other health issues.

The researchers then followed these patients for up to three years after their brain metastases were first recorded. Their main question was straightforward but important: how many people in each group died during that period?

The researchers found that patients who were taking GLP-1 drugs were significantly less likely to die during the follow-up period than those who were not. Overall, people taking GLP-1 drugs were about 37% less likely to die over the three years.

The pattern was fairly consistent across several major cancer types, including lung cancer, breast cancer and melanoma. It also appeared across different drugs within the GLP-1 class.

When researchers compared GLP-1 medicines with other modern diabetes treatments – including drugs called SGLT2 inhibitors and DPP-4 inhibitors – the GLP-1 group still seemed to fare better. That hints that something about GLP-1 signalling itself might be beneficial, rather than the effect simply coming from better blood sugar control.

Important limitation

Even so, the researchers emphasise an important limitation. This study looked back at medical records rather than testing treatments in a controlled trial. To do that, researchers would need randomised clinical trials in which patients are deliberately assigned to receive a GLP-1 drug or another treatment and then followed over time.

So how might these so-called weight-loss jabs help people whose cancer has spread to the brain?

One possibility is that they help indirectly by improving diabetes itself. Better blood sugar control, reduced body weight and improved heart health could help patients cope better with surgery, radiotherapy or chemotherapy.

But there may also be more direct effects on the brain. Scientists have discovered that GLP-1 receptors are in brain tissue and play a role in controlling inflammation, protecting nerve cells and helping maintain the blood–brain barrier – a protective layer that keeps harmful substances out of the brain.

Animal studies suggest that activating these receptors can reduce damage in brain cells and help them function properly. In theory, that might help the brain tolerate metastatic tumours better or make it a less favourable environment for cancer cells to grow. The new clinical findings are consistent with these ideas, although they do not yet tell us which mechanisms matter most in people.

For patients and families reading about this research, it is important to understand what the results do – and do not – mean. The study does not suggest that people with brain metastases should rush to start GLP-1 drugs, nor that these medicines can replace standard cancer treatments such as radiotherapy, surgery, targeted therapies or immunotherapy.

The potential benefits were seen specifically in people who already had type 2 diabetes. Like any medication, these injections can cause side-effects such as nausea and vomiting, and there are ongoing discussions about rare but serious risks.

Anyone considering them would need careful guidance from both their oncology and diabetes teams rather than making decisions based on a single study.

Still, the findings open up an intriguing new line of research linking cancer, metabolism and brain health. If future trials confirm that GLP-1 drugs genuinely improve survival in patients with brain metastases and diabetes, they could eventually become part of supportive care for people facing this difficult complication.

Kayden Walker, 12, drowned after getting into difficulty in the River Tay while on a day trip with a community group in July 2019.

A risk assessment for a river boarding trip which led to a 12-year-old boy’s death was not “suitable and sufficient”, an inquiry has heard. Kayden Walker, who could not swim, died after becoming trapped on the upstream side of a weir while on a day trip with the Church House community group in July 2019.

A Fatal Accident Inquiry (FAI) heard from Katrina Pearson, an environmental health officer with Perth and Kinross Council, who was involved in the investigation following his death. Asked by procurator fiscal depute Catherine Fraser whether she would consider the weir to be a “high risk location”, she replied “absolutely” and said the main hazard would be body entrapment.

However, she said a number of reasonable precautions could have been taken to prevent the incident. She told the inquiry on Tuesday: “In the first instance I would expect that the risk assessment for the activity would have been suitable and sufficient, which it was not in this case.

“And if it was they would have known about the hazard of the weir and the potential for body entrapment and also the risk to non swimmers and to swimmers. And I would expect that sufficient controls would be put in place to mitigate this – avoidance of the weir or not taking non-swimmers to such a high risk location, or additional supervision or robust safety briefing.”

Kayden, from Glasgow, was separated from his board during a river boarding session on the River Tay, near the village of Stanley, Perthshire, on July 28 2019. After being pulled from the water, he was airlifted to Ninewells Hospital in Dundee and was then transferred to the Royal Hospital for Children in Glasgow where he died on July 29.

The FAI, taking place at Falkirk Sheriff Court, follows the prosecution of Outdoor Pursuits Scotland Ltd in October 2024 for a contravention of health and safety legislation which led to Kayden’s death. The company was fined £10,000. Aimee Doran, representing Outdoor Pursuits, put it to Mrs Pearson that she was commenting on reasonable precautions from a health and safety point of view and without having any particular expertise in water-based activities.

Mrs Pearson replied: “Yes, from the health and safety point of view, not technical aspects.”

The joint FAI is also considering the death of Ruaridh Stevenson, 39, from Cupar, Fife, who drowned after trying to help a client who experienced difficulties in the waters flowing through Dollar Glen, Stirlingshire on April 13, 2024. Mr Stevenson was a director of a company which offered “canyoning” experiences on Scottish rivers.

The inquiry heard from Peter Carroll, a volunteer assistant ranger with the National Trust for Scotland (NTS) which cares for the area where the incident happened. He helped give CPR to Mr Stevenson after a member of the public came to tell them what was happening as he worked with NTS countryside ranger Laura Livingstone.

Mr Carroll went to the scene which was in an area called the Devil’s Cauldron which Ms Livingstone had described to the FAI as a “water feature hollowed out which forms a bowl that goes down about seven or eight feet.”

He told the inquiry: “When I looked down into the cauldron I could see Mr Stevenson on a ledge lying on his back and a chap was doing CPR.”

Mr Carroll then went to guide emergency services to the scene, which could not be reached by vehicles, before getting into the water himself to help with CPR. He said: “I was in the water until Mr Stevenson was pronounced dead and the recovery process started.”

Ms Livingstone, who has been an NTS ranger for 10 years, said the water level looked “high” on the day of the incident and she thought it was “borderline” as to whether canyoners should be in it. She told the inquiry that the area around the Devil’s Cauldron is fenced off after an incident around a decade ago where someone jumped in and died after hitting their head.

Ms Fraser asked: “Despite the fence do canyoners move the fence to access it?” to which Ms Livingstone replied, “yes.”

The inquiry also heard that there is a section nearby not managed by NTS that is not fenced off. Karen Railton, representing NTS asked: “Do you think if a sign was put up saying it was dangerous that would stop canyoners?”

Ms Livingstone said, “no.”

The FAI continues before Sheriff Keith O’Mahony.

Get more Daily Record exclusives by signing up for free to Google’s preferred sources. Click HERE.